Eledon Pharmaceuticals Inc Share Price

NASDAQ: ELDN

Small Cap

$2.46

+0.04

(+1.45%)

as on September 16, 2025 at 1:29 am IST

$₹

Eledon Pharmaceuticals Inc Stock Performance

as on September 16, 2025 at 1:29 am IST

Day's Low
Day's High
$2.42
Day's Price Range
$2.5
$2.46
1.63%
Downside
1.63%
Upside
52 Week's Low
52 Week's High
$2.38
52-Week Price Range
$5.54
$2.46
3.46%
Downside
125.20%
Upside

Eledon Pharmaceuticals Inc share price movements today

Previous Close: $2.42
Open: $2.43
Volume: 888.2K
Day's Low - High: $2.42 - $2.5
52 Week Low - High: $2.38 - $5.54

Eledon Pharmaceuticals Inc Historical Returns

1 Month Return: -7.98 %
3 Month Return: -15.68 %
1 Year Return: -8.68 %
3 Year Return: -28.82 %
5 Year Return: 0 %

Eledon Pharmaceuticals Inc Stock Fundamentals & Key Indicators

Check Eledon Pharmaceuticals Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$144.9M

EPS (TTM)

-0.845

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

3.72

Industry PE ratio

P/B Ratio

3.7231

PEG Ratio

EBITDA

-36.9M

Revenue (TTM)

Profit Margin

0.00%

Return On Equity TTM

30.03%

Eledon Pharmaceuticals Inc Stock Valuation

Track how Eledon Pharmaceuticals Inc P/E has moved over time to understand its valuation trends.

Eledon Pharmaceuticals Inc in the last 5 years

Overview
Trends

Lowest (0.00x)

September 15, 2025

Industry (0.00x)

September 15, 2025

Today (3.72x)

September 15, 2025

Highest (-0.61x)

September 30, 2023

LowHigh

Today’s Price to Earnings Ratio: 3.72x

Eledon Pharmaceuticals Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Eledon Pharmaceuticals Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Eledon Pharmaceuticals Inc	BUY	$144.9M	NA	3.72	0.00%
Alnylam Pharmaceuticals, Inc.	BUY	$61.1B	256.98%	-505.15	-12.96%
Beone Medicines Ltd	NA	$38.7B	NA	NA	-3.89%
Vertex Pharmaceuticals Incorporated	BUY	$101.1B	47.85%	28.07	31.86%
Regeneron Pharmaceuticals, Inc.	BUY	$59.4B	-3.43%	14.11	31.37%

Stock Returns calculator for Eledon Pharmaceuticals Inc Stock including INR - Dollar returns

The Eledon Pharmaceuticals Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Eledon Pharmaceuticals Inc investment value today

Current value as on today

₹97,816

Returns

₹2,184

(-2.18%)

Returns from Eledon Pharmaceuticals Inc Stock

₹7,170 (-7.17%)

Dollar Returns*

₹4,985 (+4.99%)

Analyst Recommendation on Eledon Pharmaceuticals Inc Stock

Based on 12 analysts

BUY

91.67%

Buy

8.33%

Hold

0.00%

Sell

Based on 12 analysts, 91.67% of analysts recommend a 'BUY' rating for Eledon Pharmaceuticals Inc. Average target price of $9.5

Eledon Pharmaceuticals Inc Share Price Target

Get share price movements and forecasts by analysts on Eledon Pharmaceuticals Inc.

What analysts predicted

74.11%UPSIDE

Target Price

$9.5

Current Price

$2.46

Analyzed by

12 Analysts

Target

$9.50

Eledon Pharmaceuticals Inc target price $9.5, a slight upside of 74.11% compared to current price of $2.46. According to 12 analysts rating.

Eledon Pharmaceuticals Inc Stock's Interest Amongst Investors

Search interest for Eledon Pharmaceuticals Inc Stock has increased by 76% in the last 30 days, reflecting an upward trend in search activity.

Time period: August 17, 2025 to September 16, 2025

Change:76% versus previous 30 day period

Eledon Pharmaceuticals Inc Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Total Revenue	-	-	-	-	-	0	-	0	-	-
Gross Profit	0	0	0	0	0	0	0	0	-	-
Operating Income	-11	-10	-11	-10	-10	-14	-20	-24	-17	-24
EBITDA	-11	-10	-11	-10	-10	-14	-20	-24	-17	-24
Interest Expense	0	-	-	-	-	0	-	-	-	-
Depreciation	0	0	0	0	0	0	0	0	-	-
Income Before Tax	-10	-9	-10	-9	-10	-44	76	-44	-6	-11
Income Tax Expense	0	0	0	0	0	0	-	0	-	-
Net Income	-10	-9	-10	-9	-10	-44	76	-44	-6	-11
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	-8019.11%	0.00%	-23238.02%	0.00%	0.00%

Eledon Pharmaceuticals Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	-	-	-	0	0	-	-	-
Gross Profit	0	0	0	0	0	0	0	0
Operating Income	-13	-14	-16	-18	-36	8	-43	-70
EBITDA	-13	-14	-15	-23	-36	-87	-42	-35
Interest Expense	-	-	-	9	0	0	-	-
Depreciation	0	0	0	0	0	0	0	0
Income Before Tax	-13	-14	-16	-23	-36	-87	-40	-35
Income Tax Expense	-	0	1	0	-2	0	-	0
Net Income	-13	-14	-17	-22	-34	-87	-40	-35
Net Profit Margin	0.00%	0.00%	0.00%	-19009.17%	-28755.00%	0.00%	0.00%	0.00%

Eledon Pharmaceuticals Inc Quarterly Cash Flow

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Net Income	-9	-10	-9	-10	-44	63	-44	-6	-11
Operating Cash Flow	-8	-12	-9	-8	-7	-11	-18	-16	-17
Investing Cash Flow	-30	-25	-	-	-19	-12	-47	3	14
Financing Cash Flow	33	-	-	0	48	5	80	0	-
Change in Cash	-5	-37	0	1	20	-19	13	-12	-2

Eledon Pharmaceuticals Inc Annual Cash Flow

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	-37	-13	-14	-16	-22	-34	-87	-40	-36
Operating Cash Flow	-36	-14	-11	-13	-15	-28	-28	-39	-47
Investing Cash Flow	35	23	11	11	11	-	-	-	-70
Financing Cash Flow	0	7	7	9	109	0	33	33	133
Change in Cash	0	16	-4	-4	105	-29	-28	-51	15

Global Institutional Holdings in Eledon Pharmaceuticals Inc

Funds	Holdings
Bvf Inc	10.51%
RA Capital Management, LLC	5.96%
Vanguard Group Inc	4.93%
First Light Asset Management, LLC	3.89%
Sphera Funds Management Ltd.	3.85%

See all

Insights on Eledon Pharmaceuticals Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 72.3% return, outperforming this stock by 78.9%
NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 118.7% return, outperforming this stock by 147.5%
NEGATIVE IMPACT
Price Dip
In the last 7 days, ELDN stock has moved down by -9.7%

About Eledon Pharmaceuticals Inc

eledon pharmaceuticals, inc. is a clinical stage biotechnology company using its expertise in targeting the cd40l pathway to develop potential treatments for people undergoing organ or cellular transplantation, and for people with autoimmune and neurodegenerative disease. our lead program, at-1501, is a potential best-in-class humanized igg1 anti-cd40l antibody with high affinity for cd40l, a well-validated biological target with broad therapeutic potential. the cd40/cd40l pathway plays a central role in generating pro-inflammatory responses in autoimmune disease, allograft transplant rejection, and neuroinflammation.

Organisation	Eledon Pharmaceuticals Inc
Headquarters	19800 MacArthur Boulevard, Irvine, CA, United States, 92612
CEO	Dr. David-Alexandre C. Gros M.D., Ph.D.
E-voting on shares	Click here to vote

Key Management of Eledon Pharmaceuticals Inc

Name	Title
Mr. John Herberger	Vice President of Technical Operations
Mr. Bryan E. Smith J.D.	General Counsel, Corporate Secretary & Chief Compliance Officer
Dr. David Hovland Ph.D.	Chief Regulatory Officer
Dr. Eliezer Katz F.A.C.S., FACS, M.D.	Chief Medical Officer
Ms. Marina Escudero	VP & Head of Clinical Operations
Dr. David-Alexandre C. Gros M.D., Ph.D.	CEO & Non Independent Director
Dr. Steven N. Perrin Ph.D.	President, Chief Scientific Officer & Non Independent Director
Mr. Paul Sean Little	Chief Financial Officer

FAQs

What is Eledon Pharmaceuticals Inc share price today?

Eledon Pharmaceuticals Inc share price today is $2.46 as on September 16, 2025 at 1:29 am IST at the close of the market. Eledon Pharmaceuticals Inc share today touched a day high of $2.5 and a low of $2.42.

What is the 52 week high and 52 week low for Eledon Pharmaceuticals Inc share?

Eledon Pharmaceuticals Inc share touched a 52 week high of $5.54 on November 1, 2024 and a 52 week low of $2.38 on September 30, 2024. Eledon Pharmaceuticals Inc stock price today i.e. September 16, 2025 at 1:29 am IST is closed at $2.46,which is 55.60% down from its 52 week high and 3.58% up from its 52 week low.

What is Eledon Pharmaceuticals Inc's market capitalisation today?

Eledon Pharmaceuticals Inc market capitalisation is $0.00T as on September 16, 2025 at 1:29 am IST.

How to invest in Eledon Pharmaceuticals Inc Stock (ELDN) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Eledon Pharmaceuticals Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Eledon Pharmaceuticals Inc Shares that will get you 0.6098 shares as per Eledon Pharmaceuticals Inc share price of $2.46 per share as on September 16, 2025 at 1:29 am IST.

What is the minimum amount required to buy Eledon Pharmaceuticals Inc Stock (ELDN) from India?

Indian investors can start investing in Eledon Pharmaceuticals Inc (ELDN) shares with as little as ₹88.141 or $1 (as of September 16, 2025 at 6:38 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹881.41 in Eledon Pharmaceuticals Inc stock (as per the Rupee-Dollar exchange rate as on September 16, 2025 at 6:38 am IST). Based on Eledon Pharmaceuticals Inc share’s latest price of $2.46 as on September 16, 2025 at 1:29 am IST, you will get 4.0650 shares of Eledon Pharmaceuticals Inc. Learn more about fractional shares .